Eli Lilly invests $3 billion to expand its Wisconsin factory, creating 750 jobs for drug production.
Eli Lilly is investing $3 billion to expand its Wisconsin factory to boost production of its diabetes and obesity drugs, Mounjaro and Zepbound, which generated $4.4 billion in sales last quarter. The expansion is set to begin construction next year and will add 750 jobs to the current workforce. This move is part of the company's global strategy, with over $23 billion invested in manufacturing sites since 2020.
3 months ago
74 Articles
Articles
Further Reading
You have 13 free stories remaining this month. Subscribe anytime for unlimited access.